Literature DB >> 30912697

Toxoplasma Screening Results of 84587 Pregnant Women in a Tertiary Referral Center in Turkey.

Umit Yasemin Sert1, A Seval Ozgu-Erdinc1, Sibel Gokay1, Yaprak Engin-Ustun1.   

Abstract

Aim: To determine the seroprevalence of Toxoplasma in a tertiary referral center in Turkey and to discuss the benefits and drawbacks of routine antenatal screening. Materials and methods: A serologic test for Toxoplasma is free of charge for all pregnant women as part of routine antenatal care at their first prenatal visit. The study was conducted between 2008 and 2017.
Results: The frequency of Toxoplasma IgG and IgM seropositivity was 22.3% and 0.64%, respectively. Low avidity was detected in 142 patients and 60 PCR tests were performed with no positive result. A total of 33 mothers with low IgG avidity and negative PCR received prophylactic treatment, and no congenital toxoplasmosis was documented in this study.
Conclusion: Universal screening for Toxoplasma in pregnancy is a subject of debate. As the prevalence in Turkey is higher compared to other countries, more studies are needed to identify the necessity of routine screening.

Entities:  

Keywords:  antenatal care; pregnancy; screening

Mesh:

Substances:

Year:  2019        PMID: 30912697     DOI: 10.1080/15513815.2019.1587122

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  2 in total

Review 1.  The Importance of Use of the On-line Databases as a Source for Systematic Review of Toxoplasmosis Screening During Pregnancy.

Authors:  Chrysa Voyiatzaki; Christos Orovas; Maria Trapali; Dimitrios I Chaniotis; Anastasios G Kriebardis; Apostolos Beloukas; Nikolaos D Thalassinos; Eirini Orovou; Georgios Iatrakis; Evangelia Antoniou
Journal:  Acta Inform Med       Date:  2021-09

2.  Assessment of seroprevalence of Toxoplasma gondii in blood donors applied to the blood center of Gazi university hospital.

Authors:  Ayşegül Yılmaz; Engin Yazıcı; Can Turk
Journal:  Iran J Microbiol       Date:  2021-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.